Basic concepts of Artificial Neural Networks (ANN) modeling in the application to pharmaceutical development

Pharmaceutical Development and Technology

Volumn 2, Issue 2, 1997, Pages 95-109

  Bourquin, Jacques ^a   Schmidli, Heinz ^a   Van Hoogevest, Peter ^a   Leuenberger, Hans ^b  

^a CIBA GEIGY LTD   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Artificial neural networks (ANN); Associating networks; Comparison of modeling techniques; Feature extracting networks; Learning algorithms; Nonadaptive networks; Pharmaceutical technology

Indexed keywords

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; COMPUTER ANALYSIS; COMPUTER PROGRAM; MATHEMATICAL MODEL; NERVE CELL NETWORK; PHARMACEUTICS; PRIORITY JOURNAL; RELIABILITY; STATISTICAL MODEL; SYNAPSE;

EID: 0031392564     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459709022615     Document Type: Article

References (35)

1. A. S. Hussain, Y. Xuanqjang, and R. D. Johnson, Application of neural computing in pharmaceutical product development, Pharm. Res., 8:1248-1252 (1991)
2. E. Murtoniemi, P. Merkku, and J. Yliruusi, Comparison of four different neural network training algorithms in modelling the fluidized bed granulation process. Lab. Microcomput., 12(3):69-76 (1993).
3. A. S. Hussain, P. Shivanand, and R. D. Johnson, Application of neural computing in pharmaceutical product development: Computer aided formulation design, Drug Dev. Ind. Pharm., 20(10): 1739-1752 (1994).
4. E. Murtoniemi, J. Yliruusi, P. Kinnunen, P. Merkku, and K. Leiviskä, The advantages by the use of neural networks in modelling the fluidized bed granulation process, Int. J. Pharm., 108:155-164 (1994).
5. E. Murtoniemi, P. Merkku, P. Kinnunen, K. Leiviskä, and J. Yliruusi, Effect of neural network topology and training end point in modelling the fluidized bed granulation process, Int. J. Pharm., 110:101-108 (1994).
6. M. Türkoglu, R. Ozarslan, and A. Sakr, Artificial Neural network analysis of a direct compression tabletting study, Eur. J. Pharm. Biopharm., 41(5):315-322 (1995).
7. R. J. Erb, Introduction to backpropagation neural network computation, Pharm. Res., 10(2):165-170 (1993).
8. A. S. Achanta, J. G. Kowalski, and C. T. Rhodes, Artificial neural networks: Implications for pharmaceutical sciences, Drug Dev. Ind. Pharm., 21(1):119-155 (1995).
9. T. Kohonen, An introduction to neural computing, Neural Networks, 1:3-16 (1988).
10. R. Hecht-Nielsen, Neurocomputing: Picking the human brain, IEEE Spectrum, 3:36-41 (1988).
11. W. S. Sarle, Neural networks and statistical models, Proceedings of the 19th annual SAS User Group international Conference, SAS Institute Inc., Gary NC, 1994. ftp://ftp.sas.com/pub/sugi19/neural/neurall.ps
12. Adapted from: F. H. Netter, in, Farbatlanten der Medizin (The Ciba Collection of Medical Illustrations), Band 5: Nervensystem I, Neuroanatomie und Physiologie, Georg Thieme Verlag, Stuttgart/New York, 1987, pp. 158.
13. W. S. McCulloch and W. Pitts, A logical calculus of the ideas immanent in nervous activity, Bull. Math. Biophys., 5:115-133 (1943).
14. D. O. Hebb, The Organization of Behavior, Wiley, New York, 1949.
15. F. Rosenblatt, The perceptron: A probabilistic model for information storage and organization in the brain, Psychol. Rev., 65:386-408 (1958).
16. M. Minsky and S. Papert, Perceptron, MIT Press, Cambridge, MA, 1969.
17. J. J. Hopfield, Neural networks and physical systems with emergent collective computational abilities, Proc. Natl. Acad. Sci. USA, 79:2554-2558 (1982).
18. D. E. Rumelhart, G. E. Hinton, and R. J. Williams, Learning representations by back-propagating errors, Nature, 323:533-536 (1986).
19. R. Hecht-Nielsen, Kolmogorov's mapping neural network existence theorem. Proc. First IEEE Int. Joint Conf. Neural Networks, San Diego. June 21-24, 1987, pp. III, 11-14.
20. R. Shadmehr and D. Z. D'Argenio, A neural network for nonlinear Bayesian estimation in drug therapy, Neural Comput., 2:216-225 (1990).
21. P. Veng-Pedersen and N. B. Modi, Perspective in pharmacokinetics, Neural networks in pharmacodynamic modelling. Is current modelling practice of complex kinetic system at a dead end? J. Pharmacokin. Biopharm., 20(4):397-412 (1992).
22. A. S. Hussain, R.D . Johnson, N. N. Vachharajani, and W. A. Ritschel, Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data, Pharm. Res., 10(3):466-469 (1993).
23. G. Reibnegger, G. Weiss, G. Werner-Felmayer, G. Judmaier, and H. Wachter, Neural networks as a tool for utilizing laboratory information: Comparison with linear discriminant analysis and with classification and regression trees, Proc. Natl. Acad. Sci. USA., 88:11426-11430 (1991).
24. T. A. Andrea and H. Kalayeh, Application of neural networks in quantitative structure-activity relationships of dihydrofolate reductase inhibitors, J. Med. Chem., 34:2824-2836 (1991).
25. M. L. Mavrovouniotis and S. Chang, Hierarchical neural networks, Comput. Chem. Eng., 16(4):347-369 (1992).
26. T. R. Holcomb and M. Morari, PLS/Neural networks. Comput. Chem. Eng., 16(4):393-411 (1992).
27. D. J. Livingstone and D. T. Manallack, Statistics using neural networks: Chance effects, J. Med. Chem., 36(9): 1295-1297 (1993).
28. B. P Smith and M. E. Brier, Statistical approach to neural network model building for gentamicin peak predictions, J. Pharm. Sci., 85(1):65-69 (1996).
29. W. S. Sarle, Stopped training and other remedies for overfitting, Proceedings of the 27th Symposium on the Interface 1995, SAS Institute Inc., Cary, NC, (1995). ftp://ftp.sas.com/pub/sugi19/neural/interface95.ps
30. J. E. Jackson, A User's Guide to Principal Components, Wiley, New York, 1991.
31. E. Oja, A simplified neuron modelled as a principal component analyzer, J. Math Biol., 15:267-273 (1982).
32. T. Sanger, Optimal unsupervised learning in a single layer linear feedforward network, Neural Networks, 12:459-473 (1989).
33. T. Kohonen, The self-organizing map, Proc. IEEE, 78: 1464-1480 (1990).
34. S. Grossberg, Competitive learning: From interactive activation to adaptive resonance, Cogn. Sci., 11:23-63 (1987).
35. http://wwwipd.ira.uka.de/~prechelt/FAQ/neural-net-faq.html